Compare Iovance Biotherapeutics Inc. Common Stock (IOVA) vs Kingsoft Cloud Holdings Limited (KC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Iovance Biotherapeutics Inc. Common Stock vs Kingsoft Cloud Holdings Limited — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $13.58 (market cap $6.04B), while Kingsoft Cloud Holdings Limited trades at $9.1 (market cap $2.71B). The key difference: Iovance Biotherapeutics Inc. Common Stock is far larger — about 2.2× Kingsoft Cloud Holdings Limited's market cap, and Iovance Biotherapeutics Inc. Common Stock is trading nearer its 52-week high, Kingsoft Cloud Holdings Limited nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and Kingsoft Cloud Holdings Limited for 12 Days on average.
| IOVA | KC | |
|---|---|---|
Market Cap | $6.04B | $2.71B |
Volume | 14,805,993 | 1,993,765 |
Sector | Health | Technology |
52-Week High | $14.82 | $18.21 |
52-Week Low | $1.81 | $8.58 |
Typical Hold Time | 0 Days | 12 Days |
Enterprise Value | $5.97B | $3.03B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Kingsoft Cloud (KC) trades at $9.23, down 1.28% today, with a bearish technical signal from moving averages. The company shows improving fundamentals with Q2 2026 revenue growth of 30.8% year-over-year and three consecutive earnings beats. Despite negative net income margins, gross margins improved significantly in Q2, and AI cloud services are emerging as a key growth driver. Analyst sentiment remains positive with 70% buy ratings and a consensus price target suggesting 60.3% upside potential.
The outlook is cautiously optimistic as KC transitions toward profitability, driven by AI cloud adoption and strategic partnerships. Key risks include persistent losses, competitive pressures in Chinese cloud services, and macroeconomic uncertainties. The stock offers growth potential but requires monitoring of margin improvement and cash flow sustainability amid heavy investments.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →About Kingsoft Cloud Holdings Limited
Kingsoft Cloud is a leading independent cloud service provider in China. It offers a comprehensive suite of cloud products and solutions tailored for industries like gaming, video streaming, and financial services.
Read more on KC →
